In addition to BMP1 (0.8, cancer/liver cirrhosis, p = 0.013), Trim22 was less abundant in HCC patients with normal AFP than liver cirrhosis patients, and this difference was statistically significant (0.6, cancer/liver cirrhosis, p < 0.001). This evidence concerns the gene TRIM22 and hepatocellular carcinoma.